Filter by
Selections
December 20, 2021
Arrowhead Initiates Project to Build New Manufacturing and Lab Facilities
Read MoreDecember 17, 2021
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Read MoreNovember 30, 2021
Arrowhead Pharmaceuticals to Participate in Upcoming December 2021 Conferences
Read MoreNovember 22, 2021
Arrowhead Pharmaceuticals Enters Exclusive License Agreement with GSK for ARO-HSD
Read MoreNovember 15, 2021
Arrowhead Collaborator Presents Phase 2b Clinical Data from REEF-1 Study in Patients with Chronic Hepatitis B Infection
Read MoreNovember 12, 2021